These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32377343)

  • 1. Granulomatous lymphocytic interstitial lung disease: limiting immunosuppressive therapy-a single-centre experience.
    Beaton TJ; Gillis D; Morwood K; Bint M
    Respirol Case Rep; 2020 Jul; 8(5):e00565. PubMed ID: 32377343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
    Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
    J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
    Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
    Front Immunol; 2021; 12():627423. PubMed ID: 33777011
    [No Abstract]   [Full Text] [Related]  

  • 4. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease.
    Lui VG; Ghosh T; Rymaszewski A; Chen S; Baxter RM; Kong DS; Ghosh D; Routes JM; Verbsky JW; Hsieh EWY
    J Clin Immunol; 2023 Aug; 43(6):1311-1325. PubMed ID: 37093407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
    Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
    Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
    Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
    J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
    Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.
    Lamers OAC; Smits BM; Leavis HL; de Bree GJ; Cunningham-Rundles C; Dalm VASH; Ho HE; Hurst JR; IJspeert H; Prevaes SMPJ; Robinson A; van Stigt AC; Terheggen-Lagro S; van de Ven AAJM; Warnatz K; van de Wijgert JHHM; van Montfrans J
    Front Immunol; 2021; 12():606099. PubMed ID: 33936030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulomatous-Lymphocytic Interstitial Lung Disease Mimicking Sarcoidosis.
    Perlman DM; Sudheendra MT; Racilla E; Allen TL; Joshi A; Bhargava M
    Sarcoidosis Vasc Diffuse Lung Dis; 2021; 38(3):e2021025. PubMed ID: 34744421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
    Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
    Front Immunol; 2020; 11():617985. PubMed ID: 33584710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variable immunodeficiency (CVID) with granulomatous interstitial lung disease (GLILD) and SARS COVID-19 infection: case report and review of literature.
    Pattanaik D; Ritter S; Fahhoum J
    Allergy Asthma Clin Immunol; 2021 Sep; 17(1):98. PubMed ID: 34565453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.
    van de Ven AAJM; Alfaro TM; Robinson A; Baumann U; Bergeron A; Burns SO; Condliffe AM; Fevang B; Gennery AR; Haerynck F; Jacob J; Jolles S; Malphettes M; Meignin V; Milota T; van Montfrans J; Prasse A; Quinti I; Renzoni E; Stolz D; Warnatz K; Hurst JR
    Front Immunol; 2020; 11():606333. PubMed ID: 33324422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
    Fraz MSA; Michelsen AE; Moe N; Aaløkken TM; Macpherson ME; Nordøy I; Aukrust P; Taraldsrud E; Holm AM; Ueland T; Jørgensen SF; Fevang B
    J Clin Immunol; 2022 Oct; 42(7):1553-1563. PubMed ID: 35789314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
    Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
    J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-Responsive Granulomatous-Lymphocytic Interstitial Lung Disease in a Pediatric Case of Common Variable Immunodeficiency.
    Tillman R; Guillerman RP; Trojan T; Silva-Carmona M; Chinn IK
    Front Pediatr; 2019; 7():105. PubMed ID: 30984724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.
    Bates CA; Ellison MC; Lynch DA; Cool CD; Brown KK; Routes JM
    J Allergy Clin Immunol; 2004 Aug; 114(2):415-21. PubMed ID: 15316526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatous Lymphocytic Interstitial Lung Disease Associated With Common Variable Immunodeficiency Presenting With Respiratory Failure.
    Kusaka Y; Oba T
    Cureus; 2024 Apr; 16(4):e59037. PubMed ID: 38803759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulomatous lymphocytic interstitial lung disease: description of a series of 9 cases.
    Ruiz-Alcaraz S; Gayá García-Manso I; Marco-De La Calle FM; García-Mullor MDM; López-Brull H; García-Sevila R
    Med Clin (Barc); 2021 Apr; 156(7):344-348. PubMed ID: 33478812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 18-year-old woman with Kabuki syndrome, immunoglobulin deficiency and granulomatous lymphocytic interstitial lung disease.
    De Dios JA; Javaid AA; Ballesteros E; Metersky ML
    Conn Med; 2012 Jan; 76(1):15-8. PubMed ID: 22372173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.